While the role of the ACE/AngII/AT1R axis is relatively well established in experimental models of stroke, increasing evidence now suggest that the RAS offers an endogenous cerebroprotective mechanism through the activation of the counter-regulatory RAS axis composed of ACE2/Ang-(1-7)/MasR. The gene discussed is AGT; the disease is stroke disorder.